FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry. The drug contains meloxicam as an active substance, and sodium chloride, glycine, glycofurol (tetraglycol), poloxamer (lutrol), methyl glucamine, sodium hydroxide and water for injections in the amounts specified in the patent claim. The relation of glycofurol and poloxamer makes 2:1.
EFFECT: invention provides preparing a new dosage form of meloxicam - a solution for intramuscular introduction in the integrated treatment of arthropathies accompanied by pain syndrome.
| Title | Year | Author | Number |
|---|---|---|---|
| NONSTEROID ANTIINFLAMMATORY MEDICINAL AGENT | 2007 |
|
RU2345775C1 |
| PREPARATION FOR PREVENTING AND TREATING INFLAMMATORY PROCESSES IN ANIMALS | 2019 |
|
RU2725773C1 |
| PHARMACEUTICAL SOLUTION OF MELOXICAM AND GLYCINE, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2008 |
|
RU2383344C2 |
| PHARMACEUTICAL KETOROLAC-BASED COMPOSITION IN FORM OF NASAL SPRAY AND METHOD FOR PREPARATION THEREOF | 2015 |
|
RU2611659C1 |
| ANALGETIC, SPASMOLYTIC, ANTI-INFLAMMATORY AGENT | 2001 |
|
RU2191605C1 |
| PHARMACEUTICAL PREPARATION FOR RHEUMATOLOGICAL DISEASES TREATMENT | 2016 |
|
RU2627424C1 |
| AGENT POSSESSING ANTI-INFLAMMATORY AND ANALGESIC ACTION | 2017 |
|
RU2657803C1 |
| MEDICATIONS, CONTAINING FLUOROQUINOLONES | 2007 |
|
RU2527327C2 |
| DRUG FOR SYMPTOMATIC TREATMENT OF COLDS, ACUTE RESPIRATORY AND / OR OTHER INFECTIOUS AND INFLAMMATORY DISEASES OF THE THROAT | 2021 |
|
RU2773949C1 |
| COMPOSITIONS OF LONG-TERM ACTION BASED ON KETOPROFEN | 2014 |
|
RU2646829C1 |
